Back

Impact of age and body mass index (BMI) on the short-term prognosis of Impella in patients with cardiogenic shock

27 August 2023 (10:15 - 11:00)
Organised by: Logo
Congress Presentation Part of: Prognostication and mechanical support in cardiogenic shock Cardiac Care Unit (CCU), Intensive, and Critical Cardiovascular Care ESC Professional Premium Access ESC Congress 2023 European Society of Cardiology

About the speaker

Photo
Doctor Tomoko Nakayama

Kumamoto (Japan)

8 More presentations in this session

Presentation thumbnail
Comparison of mechanical circulatory support with venoarterial extracorporeal membrane oxygenation or Impella for patients with cardiogenic shock: a propensity-matched analysis
Doctor G. Chatzis (Marburg, DE)
Abstract Slides Video
Presentation thumbnail
Characteristics and prognostic implications of pre-shock and normotensive cardiogenic shock in the Critical Care Cardiology Trials Network Registry
Doctor S. Patel (Boston, US)
Abstract Slides Video
Presentation thumbnail
Combined use of VA-ECMO and Impella (ECPELLA) improves short- and long-term mortality in patients with cardiogenic shock who received VA-ECMO
Doctor T. Unoki (Kumamoto, JP)
Abstract Slides Video
Presentation thumbnail
Trends in mechanical circulatory support use and outcomes of patients with cardiogenic shock in Japan, 2010-2020: a nationwide inpatient database study
Doctor Y. Nishimoto (Toyonaka, JP)
Abstract Slides Video
Presentation thumbnail
Validation of SAVE score and the value of serum lactate in patients admitted for cardiogenic shock treated with VA-ECMO
Doctor A. Bello (Carnaxide, PT)
Abstract Slides Video

Access the full session

Session thumbnail
Prognostication and mechanical support in cardiogenic shock

The Event

Event poster

ESC Congress 2023

27 August 2023 10:15 CET
You may be interested in
thumbnail
Congress Presentation
Cardiogenic shock and comorbidities: can we predict mortality by baseline characteristics?
thumbnail
Congress Presentation
Procedural volume and outcomes in patients with cardiogenic shock who received Impella: insight from the J-PVAD Registry
thumbnail
Congress Presentation
Short-term outcomes of impella support in japanese patients with cardiogenic shock due to non-ischemic cardiomyopathy

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources